Baptist Diabetes Associates

Miami, Florida 33176

0 studies enrolling now · 16 studies all time

What they study most

Diabetes, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II, Gastroparesis, Type 2 Diabetes Mellitus

Studies at this site

• Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control — Completed
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes — Completed
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone — Completed
• Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus — Completed
• Extension Study for 2993-112 — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin — Completed
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus — Completed
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus — Completed
• Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea — Completed
• Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes — Completed
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) — Completed
• Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis — Completed